ghk-cu injection fda approval status Is FDA-Approved? - News GHK-Cu Dosage Protocol Injection Guide

+ Can BPC-157 be combined with other recovery peptides

Quick answer Documented research protocols reconstitute the CJC-1295 DAC + Ipamorelin (2+5 mg) stack vial with about 1 mL of bacteriostatic water, referencing a reported research dose near 1 mg per administration from that solution

In clinical practice, the addition of BPC-157 has been associated with improved rather than worsened GI tolerance, consistent with BPC-157's known gastroprotective pharmacology

This mix is very popular for musculoskeletal injuries

The research is conflicting, and no human studies have definitively established either benefit or harm in cancer patients